Ever Source Wealth Advisors, LLC Kura Oncology, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 782 shares of KURA stock, worth $7,921. This represents 0.0% of its overall portfolio holdings.
Number of Shares
782
Previous 397
96.98%
Holding current value
$7,921
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding KURA
# of Institutions
191Shares Held
79.9MCall Options Held
53.6KPut Options Held
42.8K-
Suvretta Capital Management, LLC New York, NY8.12MShares$82.2 Million1.61% of portfolio
-
Bvf Inc San Francisco, CA7.75MShares$78.5 Million1.76% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$70.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.2MShares$62.8 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$54.2 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $678M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...